These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 18657420)
1. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part II: Folic acid conjugates of tubulysins and their hydrazides. Vlahov IR; Wang Y; Kleindl PJ; Leamon CP Bioorg Med Chem Lett; 2008 Aug; 18(16):4558-61. PubMed ID: 18657420 [TBL] [Abstract][Full Text] [Related]
2. Design and regioselective synthesis of a new generation of targeted chemotherapeutics. Part 1: EC145, a folic acid conjugate of desacetylvinblastine monohydrazide. Vlahov IR; Santhapuram HK; Kleindl PJ; Howard SJ; Stanford KM; Leamon CP Bioorg Med Chem Lett; 2006 Oct; 16(19):5093-6. PubMed ID: 16870437 [TBL] [Abstract][Full Text] [Related]
3. Regioselective synthesis of folate receptor-targeted agents derived from epothilone analogs and folic acid. Vlahov IR; Vite GD; Kleindl PJ; Wang Y; Santhapuram HK; You F; Howard SJ; Kim SH; Lee FF; Leamon CP Bioorg Med Chem Lett; 2010 Aug; 20(15):4578-81. PubMed ID: 20594844 [TBL] [Abstract][Full Text] [Related]
4. In vivo structural activity and optimization studies of folate-tubulysin conjugates. Reddy JA; Dorton R; Dawson A; Vetzel M; Parker N; Nicoson JS; Westrick E; Klein PJ; Wang Y; Vlahov IR; Leamon CP Mol Pharm; 2009; 6(5):1518-25. PubMed ID: 19630399 [TBL] [Abstract][Full Text] [Related]
5. Design and regioselective synthesis of a new generation of targeted therapeutics. Part 3: Folate conjugates of aminopterin hydrazide for the treatment of inflammation. Vlahov IR; You F; Santhapuram HK; Wang Y; Vaughn JF; Hahn SJ; Kleindl PJ; Fan M; Leamon CP Bioorg Med Chem Lett; 2011 Feb; 21(4):1202-5. PubMed ID: 21236665 [TBL] [Abstract][Full Text] [Related]
6. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue. Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164 [TBL] [Abstract][Full Text] [Related]
7. [Folate receptor-mediated antitumor drugs]. Zhao J; Cao SL; Zheng XL; Zhao B Yao Xue Xue Bao; 2009 Feb; 44(2):109-14. PubMed ID: 19408677 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of EC72: a new folate-targeted chemotherapeutic. Leamon CP; Reddy JA; Vlahov IR; Vetzel M; Parker N; Nicoson JS; Xu LC; Westrick E Bioconjug Chem; 2005; 16(4):803-11. PubMed ID: 16029021 [TBL] [Abstract][Full Text] [Related]
9. An assembly concept for the consecutive introduction of unsymmetrical disulfide bonds: synthesis of a releasable multidrug conjugate of folic acid. Vlahov IR; Santhapuram HK; Wang Y; Kleindl PJ; You F; Howard SJ; Westrick E; Reddy JA; Leamon CP J Org Chem; 2007 Aug; 72(16):5968-72. PubMed ID: 17602528 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and activity of a folate peptide camptothecin prodrug. Henne WA; Doorneweerd DD; Hilgenbrink AR; Kularatne SA; Low PS Bioorg Med Chem Lett; 2006 Oct; 16(20):5350-5. PubMed ID: 16901694 [TBL] [Abstract][Full Text] [Related]
12. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate. Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697 [TBL] [Abstract][Full Text] [Related]
13. Folate receptor specific anti-tumor activity of folate-mitomycin conjugates. Reddy JA; Westrick E; Vlahov I; Howard SJ; Santhapuram HK; Leamon CP Cancer Chemother Pharmacol; 2006 Aug; 58(2):229-36. PubMed ID: 16331500 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of releasable folate-drug conjugates using a novel heterobifunctional disulfide-containing linker. Satyam A Bioorg Med Chem Lett; 2008 Jun; 18(11):3196-9. PubMed ID: 18468892 [TBL] [Abstract][Full Text] [Related]
15. Targeting the folate receptor (FR): imaging and cytotoxicity of ReI conjugates in FR-overexpressing cancer cells. Viola-Villegas N; Rabideau AE; Cesnavicious J; Zubieta J; Doyle RP ChemMedChem; 2008 Sep; 3(9):1387-94. PubMed ID: 18651631 [TBL] [Abstract][Full Text] [Related]
16. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298 [TBL] [Abstract][Full Text] [Related]
17. Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy. Leamon CP; Reddy JA; Vlahov IR; Dorton R; Bloomfield A; Vetzel M; Klein PJ; Westrick E; Xu LC; Wang Y Cancer Chemother Pharmacol; 2017 Jun; 79(6):1151-1160. PubMed ID: 28451831 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugate. Leamon CP; Reddy JA; Vlahov IR; Kleindl PJ; Vetzel M; Westrick E Bioconjug Chem; 2006; 17(5):1226-32. PubMed ID: 16984132 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases. Henne WA; Kularatne SA; Ayala-López W; Doorneweerd DD; Stinnette TW; Lu Y; Low PS Bioorg Med Chem Lett; 2012 Jan; 22(1):709-12. PubMed ID: 22100311 [TBL] [Abstract][Full Text] [Related]
20. Folate receptor-mediated targeting of liposomal drugs to cancer cells. Stephenson SM; Low PS; Lee RJ Methods Enzymol; 2004; 387():33-50. PubMed ID: 15172156 [No Abstract] [Full Text] [Related] [Next] [New Search]